Literature DB >> 9077067

[The basics for establishing a needlestick injury prevention program in hospitals].

K Kidouchi1, M Kashiwamata, C Nakamura, T Katoh, Y Mizuno, S Watanabe.   

Abstract

Although the risk of occupationally acquired infection is a matter of considerable concern for health care workers, the problem of needlestick injuries has yet to be fully understood in Japan. We investigated 257 cases of needlestick injuries in five Nagoya Municipal Hospitals from 1989 to 1994 using the Japan EPInet. The number of needlestick injuries increased each year of the study. In one of these hospitals, the Higashi Municipal Hospital, a specialist committee began activities in April, 1993, and protective equipment and devices were also introduced during 1994. HCV contamination injuries accounted for 70%-80% of the total number of injuries reported during the 1991-1994 period at the four hospitals and during 1991-1992 period at the Higashi Municipal Hospital. At the Higashi Municipal Hospital, HCV contamination injuries decreased from 22 cases (48%) in 1993, to 15 cases (25%) in 1994. The use of the Japanese EPINet for analytical purposes enabled us to clearly identify the causes and status of needlestick injuries, resulting in the establishment of an effective prevention program.

Entities:  

Mesh:

Year:  1997        PMID: 9077067     DOI: 10.11150/kansenshogakuzasshi1970.71.108

Source DB:  PubMed          Journal:  Kansenshogaku Zasshi        ISSN: 0387-5911


  2 in total

1.  Incidence rate of needlestick and sharps injuries in 67 Japanese hospitals: a national surveillance study.

Authors:  Toru Yoshikawa; Koji Wada; Jong Ja Lee; Toshihiro Mitsuda; Kiyoshi Kidouchi; Hitomi Kurosu; Yuji Morisawa; Mayumi Aminaka; Takashi Okubo; Satoshi Kimura; Kyoji Moriya
Journal:  PLoS One       Date:  2013-10-30       Impact factor: 3.240

2.  Estimating the national cost burden of in-hospital needlestick injuries among healthcare workers in Japan.

Authors:  Hiroyuki Kunishima; Emiko Yoshida; Joe Caputo; Hiroshige Mikamo
Journal:  PLoS One       Date:  2019-11-07       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.